FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143237216> ?p ?o ?g. }

• W2143237216 endingPage "2306" @default.
• W2143237216 startingPage "2296" @default.
• W2143237216 abstract "We aimed to assess the safety and efficacy of thrombectomy for the treatment of stroke in a trial embedded within a population-based stroke reperfusion registry.During a 2-year period at four centers in Catalonia, Spain, we randomly assigned 206 patients who could be treated within 8 hours after the onset of symptoms of acute ischemic stroke to receive either medical therapy (including intravenous alteplase when eligible) and endovascular therapy with the Solitaire stent retriever (thrombectomy group) or medical therapy alone (control group). All patients had confirmed proximal anterior circulation occlusion and the absence of a large infarct on neuroimaging. In all study patients, the use of alteplase either did not achieve revascularization or was contraindicated. The primary outcome was the severity of global disability at 90 days, as measured on the modified Rankin scale (ranging from 0 [no symptoms] to 6 [death]). Although the maximum planned sample size was 690, enrollment was halted early because of loss of equipoise after positive results for thrombectomy were reported from other similar trials.Thrombectomy reduced the severity of disability over the range of the modified Rankin scale (adjusted odds ratio for improvement of 1 point, 1.7; 95% confidence interval [CI], 1.05 to 2.8) and led to higher rates of functional independence (a score of 0 to 2) at 90 days (43.7% vs. 28.2%; adjusted odds ratio, 2.1; 95% CI, 1.1 to 4.0). At 90 days, the rates of symptomatic intracranial hemorrhage were 1.9% in both the thrombectomy group and the control group (P=1.00), and rates of death were 18.4% and 15.5%, respectively (P=0.60). Registry data indicated that only eight patients who met the eligibility criteria were treated outside the trial at participating hospitals.Among patients with anterior circulation stroke who could be treated within 8 hours after symptom onset, stent retriever thrombectomy reduced the severity of post-stroke disability and increased the rate of functional independence. (Funded by Fundació Ictus Malaltia Vascular through an unrestricted grant from Covidien and others; REVASCAT ClinicalTrials.gov number, NCT01692379.)." @default.
• W2143237216 created "2016-06-24" @default.
• W2143237216 creator A5000039714 @default.
• W2143237216 creator A5003196347 @default.
• W2143237216 creator A5005513572 @default.
• W2143237216 creator A5015863703 @default.
• W2143237216 creator A5019880814 @default.
• W2143237216 creator A5020165084 @default.
• W2143237216 creator A5020830333 @default.
• W2143237216 creator A5021015644 @default.
• W2143237216 creator A5021227220 @default.
• W2143237216 creator A5022280097 @default.
• W2143237216 creator A5029093093 @default.
• W2143237216 creator A5030307585 @default.
• W2143237216 creator A5035702252 @default.
• W2143237216 creator A5063275381 @default.
• W2143237216 creator A5064697751 @default.
• W2143237216 creator A5065790633 @default.
• W2143237216 creator A5072522471 @default.
• W2143237216 creator A5075245949 @default.
• W2143237216 creator A5078791960 @default.
• W2143237216 creator A5080100010 @default.
• W2143237216 creator A5086223785 @default.
• W2143237216 creator A5087529597 @default.
• W2143237216 date "2015-06-11" @default.
• W2143237216 modified "2023-10-18" @default.
• W2143237216 title "Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke" @default.
• W2143237216 cites W1981780579 @default.
• W2143237216 cites W1997414654 @default.
• W2143237216 cites W2058384458 @default.
• W2143237216 cites W2060832182 @default.
• W2143237216 cites W2096850169 @default.
• W2143237216 cites W2098032054 @default.
• W2143237216 cites W2111559905 @default.
• W2143237216 cites W2119542322 @default.
• W2143237216 cites W2139621750 @default.
• W2143237216 cites W2161128340 @default.
• W2143237216 cites W2164763924 @default.
• W2143237216 cites W2168109100 @default.
• W2143237216 cites W2171058244 @default.
• W2143237216 doi "https://doi.org/10.1056/nejmoa1503780" @default.
• W2143237216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25882510" @default.
• W2143237216 hasPublicationYear "2015" @default.
• W2143237216 type Work @default.
• W2143237216 sameAs 2143237216 @default.
• W2143237216 citedByCount "3797" @default.
• W2143237216 countsByYear W21432372162014 @default.
• W2143237216 countsByYear W21432372162015 @default.
• W2143237216 countsByYear W21432372162016 @default.
• W2143237216 countsByYear W21432372162017 @default.
• W2143237216 countsByYear W21432372162018 @default.
• W2143237216 countsByYear W21432372162019 @default.
• W2143237216 countsByYear W21432372162020 @default.
• W2143237216 countsByYear W21432372162021 @default.
• W2143237216 countsByYear W21432372162022 @default.
• W2143237216 countsByYear W21432372162023 @default.
• W2143237216 crossrefType "journal-article" @default.
• W2143237216 hasAuthorship W2143237216A5000039714 @default.
• W2143237216 hasAuthorship W2143237216A5003196347 @default.
• W2143237216 hasAuthorship W2143237216A5005513572 @default.
• W2143237216 hasAuthorship W2143237216A5015863703 @default.
• W2143237216 hasAuthorship W2143237216A5019880814 @default.
• W2143237216 hasAuthorship W2143237216A5020165084 @default.
• W2143237216 hasAuthorship W2143237216A5020830333 @default.
• W2143237216 hasAuthorship W2143237216A5021015644 @default.
• W2143237216 hasAuthorship W2143237216A5021227220 @default.
• W2143237216 hasAuthorship W2143237216A5022280097 @default.
• W2143237216 hasAuthorship W2143237216A5029093093 @default.
• W2143237216 hasAuthorship W2143237216A5030307585 @default.
• W2143237216 hasAuthorship W2143237216A5035702252 @default.
• W2143237216 hasAuthorship W2143237216A5063275381 @default.
• W2143237216 hasAuthorship W2143237216A5064697751 @default.
• W2143237216 hasAuthorship W2143237216A5065790633 @default.
• W2143237216 hasAuthorship W2143237216A5072522471 @default.
• W2143237216 hasAuthorship W2143237216A5075245949 @default.
• W2143237216 hasAuthorship W2143237216A5078791960 @default.
• W2143237216 hasAuthorship W2143237216A5080100010 @default.
• W2143237216 hasAuthorship W2143237216A5086223785 @default.
• W2143237216 hasAuthorship W2143237216A5087529597 @default.
• W2143237216 hasBestOaLocation W21432372161 @default.
• W2143237216 hasConcept C126322002 @default.
• W2143237216 hasConcept C127413603 @default.
• W2143237216 hasConcept C141071460 @default.
• W2143237216 hasConcept C156957248 @default.
• W2143237216 hasConcept C168563851 @default.
• W2143237216 hasConcept C190659310 @default.
• W2143237216 hasConcept C2779464278 @default.
• W2143237216 hasConcept C2780645631 @default.
• W2143237216 hasConcept C2780931571 @default.
• W2143237216 hasConcept C2908647359 @default.
• W2143237216 hasConcept C3020199598 @default.
• W2143237216 hasConcept C44249647 @default.
• W2143237216 hasConcept C500558357 @default.
• W2143237216 hasConcept C541997718 @default.
• W2143237216 hasConcept C71924100 @default.
• W2143237216 hasConcept C78519656 @default.
• W2143237216 hasConcept C99454951 @default.
• W2143237216 hasConceptScore W2143237216C126322002 @default.

• next